SHE:000513 Revenue

Livzon Pharmaceutical Group had revenue of 3.09B CNY in the quarter ending June 30, 2025, with 1.71% growth. This brings the company's revenue in the last twelve months to 11.80B, down -1.83% year-over-year. In the year 2024, Livzon Pharmaceutical Group had annual revenue of 11.81B, down -4.97%.

Revenue (ttm)

11.80B

Revenue Growth

-1.83%

P/S Ratio

2.69

Revenue / Employee

1.30M

Employees

9,067

Market Cap

31.80B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.81B	-617.70M	-4.97%
Dec 31, 2023	12.43B	-199.54M	-1.58%
Dec 31, 2022	12.63B	565.72M	4.69%
Jan 1, 2022	12.06B	1.54B	14.67%
Jan 1, 2021	10.52B	1.14B	12.10%
Jan 1, 2020	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Jan 1, 2018	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	30.15B
WuXi AppTec	41.90B
Shenzhen Mindray Bio-Medical Electronics	32.94B
Sichuan Biokin Pharmaceutical	441.19M
Shanghai United Imaging Healthcare	10.98B
Zhangzhou Pientzehuang Pharmaceutical.,	10.52B
Aier Eye Hospital Group	21.94B
Yunnan Baiyao Group Co.,Ltd	40.84B

Revenue Rankings